Laurion Capital Management LP Xenon Pharmaceuticals Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$36.25 - $43.75 $2.46 Million - $2.97 Million
-67,931 Reduced 28.41%
171,195 $6.67 Million
Q1 2024

May 15, 2024
BUY
$42.66 - $50.04 $7 Million - $8.21 Million
164,126 Added 218.83%
239,126 $10.3 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $2.15 Million - $3.48 Million
75,000 New
75,000 $3.45 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $254,400 - $351,599
10,000 New
10,000 $304,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email